[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

BLPH Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $5,611,403.53

Bellerophon Therapeutics Insider Trading History Chart

Bellerophon Therapeutics Share Price & Price History

^$0.03

+0.30 (1.20%)

As of 11/28/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Bellerophon Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/13/2023	Puissance Capital Management L	Major Shareholder	Sell	1,076,841	$0.10	$107,684.10
6/7/2023	Life Science Opportu Puissance	Major Shareholder	Sell	134,421	$0.83	$111,569.43	1,076,841
5/18/2023	Bobae Kim	VP	Sell	9,455	$10.00	$94,550.00	1,723
5/18/2023	Life Science Opportu Puissance	Major Shareholder	Sell	560,000	$9.46	$5,297,600.00	1,211,262
3/18/2021	New Mountain Investments Ii, L	Major Shareholder	Sell	400,000	$5.48	$2,192,000.00

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Bellerophon Therapeutics (NASDAQ:BLPH)

28.88% of Bellerophon Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Bellerophon Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/11/2023	Renaissance Technologies LLC	77,299	$53K	0.0%	-54.5%	0.740%
8/11/2023	BlackRock Inc.	129,876	$90K	0.0%	+34.8%	1.243%
8/7/2023	Acadian Asset Management LLC	265,253	$0.18M	0.0%	N/A	2.538%
5/16/2023	Perceptive Advisors LLC	930,000	$7.34M	0.2%	N/A	8.900%
5/16/2023	State Street Corp	30,127	$0.24M	0.0%	+41.3%	0.288%
5/16/2023	Geode Capital Management LLC	95,656	$0.76M	0.0%	+49.0%	0.915%
5/12/2023	Renaissance Technologies LLC	169,899	$1.34M	0.0%	-1.1%	1.626%
5/12/2023	BlackRock Inc.	96,349	$0.76M	0.0%	-4.2%	0.922%
5/12/2023	Dimensional Fund Advisors LP	13,585	$0.11M	0.0%	N/A	0.130%
2/13/2023	Wells Fargo & Company MN	191,065	$0.17M	0.0%	-4.5%	2.001%
2/13/2023	Renaissance Technologies LLC	171,799	$0.16M	0.0%	-12.4%	1.799%
2/10/2023	HRT Financial LP	28,035	$25K	0.0%	N/A	0.294%
11/17/2022	Telemetry Investments L.L.C.	47,500	$52K	0.1%	-31.2%	0.497%
11/15/2022	Vanguard Group Inc.	345,194	$0.38M	0.0%	-4.3%	3.616%
11/14/2022	Renaissance Technologies LLC	196,191	$0.21M	0.0%	-6.3%	2.055%
8/13/2022	Renaissance Technologies LLC	209,399	$0.26M	0.0%	+13.0%	2.194%
7/26/2022	Sepio Capital LP	23,800	$29K	0.0%	N/A	0.249%
5/17/2022	Jane Street Group LLC	37,327	$88K	0.0%	-49.6%	0.391%
11/16/2021	Telemetry Investments L.L.C.	85,500	$0.35M	0.5%	-6.0%	0.899%
11/12/2021	Renaissance Technologies LLC	201,706	$0.82M	0.0%	-21.5%	2.122%
11/9/2021	BlackRock Inc.	120,620	$0.49M	0.0%	+3.6%	1.268%
9/17/2021	Virtu Financial LLC	16,495	$80K	0.0%	N/A	0.174%
8/16/2021	Telemetry Investments L.L.C.	90,920	$0.44M	0.6%	+48.9%	0.956%
8/16/2021	State Street Corp	21,027	$0.10M	0.0%	-63.1%	0.221%
8/13/2021	Renaissance Technologies LLC	257,072	$1.24M	0.0%	+10.0%	2.704%
8/13/2021	Northern Trust Corp	36,555	$0.18M	0.0%	-51.6%	0.385%
8/13/2021	Geode Capital Management LLC	58,380	$0.28M	0.0%	-8.0%	0.614%
8/13/2021	Vanguard Group Inc.	336,966	$1.63M	0.0%	-6.2%	3.545%
8/12/2021	JPMorgan Chase & Co.	6,507	$31K	0.0%	+242.5%	0.068%
8/12/2021	Ergoteles LLC	13,800	$67K	0.0%	N/A	0.145%
5/21/2021	Citadel Advisors LLC	20,000	$0.10M	0.0%	N/A	0.210%
5/19/2021	Squarepoint Ops LLC	14,569	$76K	0.0%	N/A	0.153%
5/18/2021	New Mountain Vantage Advisers L.L.C.	252,650	$3.16M	0.1%	-75.0%	2.658%
5/18/2021	Tudor Investment Corp Et Al	20,000	$0.10M	0.0%	N/A	0.210%
5/18/2021	Citadel Advisors LLC	20,000	$0.10M	0.0%	N/A	0.210%
5/17/2021	Caas Capital Management LP	97,900	$0.51M	0.0%	N/A	1.030%
5/14/2021	Laurion Capital Management LP	20,000	$0.10M	0.0%	N/A	0.210%
5/13/2021	Renaissance Technologies LLC	233,799	$1.21M	0.0%	+9.1%	2.459%
5/12/2021	Northern Trust Corp	75,579	$0.39M	0.0%	-15.7%	0.795%
5/11/2021	Element Capital Management LLC	11,646	$60K	0.0%	N/A	0.123%
5/10/2021	GSA Capital Partners LLP	63,566	$0.33M	0.1%	+6.7%	0.669%
5/7/2021	BlackRock Inc.	321,782	$1.67M	0.0%	+2.3%	3.385%
4/28/2021	DAVENPORT & Co LLC	98,975	$0.51M	0.0%	+10.9%	1.041%
2/19/2021	JPMorgan Chase & Co.	10,701	$72K	0.0%	+261.4%	0.113%
2/12/2021	LPL Financial LLC	10,080	$67K	0.0%	N/A	0.106%
2/11/2021	Northern Trust Corp	89,607	$0.60M	0.0%	-2.8%	0.943%
2/10/2021	Renaissance Technologies LLC	214,299	$1.43M	0.0%	-13.7%	2.256%
2/9/2021	Wells Fargo & Company MN	202,330	$1.35M	0.0%	+83.5%	2.130%
2/5/2021	BlackRock Inc.	314,617	$2.10M	0.0%	+9.8%	3.312%
2/4/2021	GSA Capital Partners LLP	59,589	$0.40M	0.1%	+112.1%	0.627%
11/16/2020	AQR Capital Management LLC	34,071	$0.35M	0.0%	N/A	0.359%
11/10/2020	State Street Corp	59,077	$0.60M	0.0%	+82.9%	0.622%
11/6/2020	GSA Capital Partners LLP	28,092	$0.29M	0.0%	N/A	0.296%
11/5/2020	First Trust Advisors LP	20,415	$0.21M	0.0%	N/A	0.215%
11/5/2020	Wells Fargo & Company MN	110,236	$1.12M	0.0%	+6,163.4%	1.161%
10/30/2020	WINTON GROUP Ltd	12,498	$0.13M	0.0%	N/A	0.132%
10/15/2020	DAVENPORT & Co LLC	94,475	$0.96M	0.0%	-11.8%	0.994%
8/25/2020	Nuveen Asset Management LLC	21,592	$0.27M	0.0%	N/A	0.227%
8/20/2020	Charles Schwab Investment Management Inc.	11,586	$0.15M	0.0%	N/A	0.122%
8/14/2020	Bank of America Corp DE	6,501	$82K	0.0%	+49,907.7%	0.068%
8/14/2020	Telemetry Investments L.L.C.	125,000	$1.57M	4.3%	+150.0%	1.316%
8/12/2020	American International Group Inc.	2,105	$26K	0.0%	N/A	0.022%
8/12/2020	Tocqueville Asset Management L.P.	25,400	$0.32M	0.0%	+124.8%	0.267%
8/7/2020	New York State Common Retirement Fund	8,000	$100K	0.0%	N/A	0.084%
7/28/2020	DAVENPORT & Co LLC	107,150	$1.35M	0.0%	N/A	1.128%
6/24/2020	New Mountain Vantage Advisers L.L.C.	100,231	$16.92M	0.9%	-99.3%	1.635%
5/15/2020	Morgan Stanley	2,633	$29K	0.0%	+426.6%	0.043%
5/15/2020	Telemetry Investments L.L.C.	50,000	$0.55M	1.9%	-85.2%	0.815%
5/15/2020	New Mountain Vantage Advisers L.L.C.	100,231	$16.92M	0.9%	-99.3%	1.635%
5/14/2020	Credit Agricole S A	3,160	$35K	0.0%	N/A	0.052%
2/13/2020	Renaissance Technologies LLC	1,679,303	$0.59M	0.0%	+7.8%	36.650%
2/4/2020	Virtu Financial LLC	76,989	$27K	0.0%	+97.3%	0.112%
8/14/2019	Vanguard Group Inc.	1,152,175	$0.69M	0.0%	+15.9%	1.672%
8/12/2019	Renaissance Technologies LLC	1,434,538	$0.86M	0.0%	+8.9%	2.082%
8/10/2019	LPL Financial LLC	130,800	$78K	0.0%	+22.1%	0.190%
5/14/2019	Arch Venture Corp	965,660	$0.63M	0.6%	N/A	1.401%
2/13/2019	Geode Capital Management LLC	232,890	$0.19M	0.0%	+13.1%	0.338%
1/16/2019	Virtu Financial LLC	36,708	$29K	0.0%	+60.2%	0.063%
12/13/2018	Vanguard Group Inc	1,023,533	$1.11M	0.0%	+2.5%	1.744%
11/13/2018	VHCP Management III LLC	2,274,370	$2.46M	1.9%	N/A	3.876%
11/13/2018	Renaissance Technologies LLC	1,213,276	$1.31M	0.0%	+4.7%	2.068%
8/13/2018	Renaissance Technologies LLC	1,159,200	$2.81M	0.0%	+12.2%	2.006%
5/14/2018	DRW Securities LLC	70,000	$0.15M	0.0%	N/A	0.122%
2/13/2018	Renaissance Technologies LLC	927,200	$2.39M	0.0%	+25.3%	1.680%
2/12/2018	EAM Investors LLC	237,975	$0.61M	0.1%	N/A	0.431%
2/9/2018	Virtu Financial LLC	56,569	$0.15M	0.0%	N/A	0.103%
2/9/2018	Bank of New York Mellon Corp	177,429	$0.46M	0.0%	N/A	0.322%
11/13/2017	VHCP Management II LLC	4,149,378	$4.72M	1.3%	N/A	7.520%
8/15/2017	Susquehanna International Group LLP	981,847	$1.32M	0.0%	N/A	2.765%
8/15/2017	New Mountain Vantage Advisers L.L.C.	10,574,171	$14.17M	1.0%	No Change	29.778%
8/11/2017	FMR LLC	1,108,470	$1.49M	0.0%	-3.0%	3.360%
5/18/2017	Goldman Sachs Group Inc.	84,006	$0.13M	0.0%	N/A	0.262%
5/15/2017	Boxer Capital LLC	1,857,143	$2.77M	0.6%	No Change	5.797%
5/12/2017	Renaissance Technologies LLC	477,400	$0.71M	0.0%	+99.7%	1.490%
5/11/2017	FMR LLC	1,142,970	$1.70M	0.0%	-5.4%	3.567%
2/15/2017	Armistice Capital LLC	1,000,000	$0.52M	0.1%	N/A	6.894%
2/14/2017	Boxer Capital LLC	1,857,143	$0.97M	0.4%	N/A	12.803%
2/13/2017	Renaissance Technologies LLC	239,100	$0.12M	0.0%	+330.8%	1.648%
2/10/2017	FMR LLC	1,208,070	$0.63M	0.0%	No Change	8.328%
11/14/2016	New Mountain Vantage Advisers L.L.C.	4,859,885	$6.80M	0.4%	No Change	33.289%

Data available starting January 2016

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse, which is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.

Today's Range

Now: $0.03

$0.03

$0.04

50 Day Range

MA: $0.17

$0.03

$0.44

52 Week Range

Now: $0.03

$0.03

$12.58

Volume

14,651 shs

Average Volume

907,901 shs

Market Capitalization

$410,928.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72

Who are the company insiders with the largest holdings of Bellerophon Therapeutics?: Bellerophon Therapeutics' top insider shareholders include:
Life Science Opportu Puissance (Major Shareholder)
Bobae Kim (VP)
Puissance Capital Management L (Major Shareholder)
Learn More about top insider investors at Bellerophon Therapeutics.
Who are the major institutional investors of Bellerophon Therapeutics?: Bellerophon Therapeutics' top institutional shareholders include:
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Bellerophon Therapeutics stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

BLPH Insider Trading

Bellerophon Therapeutics Insider Trading History Chart

Bellerophon Therapeutics Share Price & Price History

Bellerophon Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Bellerophon Therapeutics (NASDAQ:BLPH)

Institutional Buying and Selling by Quarter

Bellerophon Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Bellerophon Therapeutics?

Who are the major institutional investors of Bellerophon Therapeutics?